Ancora Advisors, LLC Pfizer Inc Transaction History

Ancora Advisors, LLC

  • $3.73 Billion
  • Q2 2024

A detailed history of Ancora Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ancora Advisors, LLC holds 242,546 shares of PFE stock, worth $6.48 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
242,546
Previous 255,277 4.99%
Holding current value
$6.48 Million
Previous $7.08 Million 4.19%
% of portfolio
0.18%
Previous 0.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$25.26 - $29.6 $321,585 - $376,837
-12,731 Reduced 4.99%
242,546 $6.79 Million
Q1 2024

May 15, 2024
BUY
$25.89 - $29.73 $174,938 - $200,885
6,757 Added 2.72%
255,277 $7.08 Million
Q4 2023

Feb 14, 2024
BUY
$26.13 - $33.94 $1.78 Million - $2.31 Million
68,102 Added 37.75%
248,520 $7.15 Million
Q3 2023

Nov 14, 2023
SELL
$32.09 - $37.51 $217,506 - $254,242
-6,778 Reduced 3.62%
180,418 $5.98 Million
Q2 2023

Aug 14, 2023
BUY
$36.12 - $41.79 $92,394 - $106,898
2,558 Added 1.39%
187,196 $6.87 Million
Q1 2023

May 15, 2023
BUY
$39.39 - $51.28 $98,081 - $127,687
2,490 Added 1.37%
184,638 $7.53 Million
Q4 2022

Feb 14, 2023
BUY
$41.75 - $54.5 $701,817 - $916,145
16,810 Added 10.17%
182,148 $9.33 Million
Q3 2022

Nov 14, 2022
BUY
$43.76 - $53.42 $125,197 - $152,834
2,861 Added 1.76%
165,338 $7.24 Million
Q2 2022

Aug 15, 2022
SELL
$46.53 - $55.17 $673,056 - $798,034
-14,465 Reduced 8.17%
162,477 $8.52 Million
Q1 2022

May 16, 2022
SELL
$45.75 - $56.69 $83,173 - $103,062
-1,818 Reduced 1.02%
176,942 $9.16 Million
Q1 2022

May 13, 2022
SELL
$45.75 - $56.69 $245,631 - $304,368
-5,369 Reduced 2.92%
178,760 $6.48 Million
Q4 2021

Feb 14, 2022
SELL
$41.32 - $61.25 $31,857 - $47,223
-771 Reduced 0.42%
184,129 $10.9 Million
Q3 2021

Nov 15, 2021
BUY
$39.25 - $50.42 $164,379 - $211,158
4,188 Added 2.32%
184,900 $7.95 Million
Q2 2021

Aug 13, 2021
BUY
$35.91 - $40.68 $70,096 - $79,407
1,952 Added 1.09%
180,712 $7.08 Million
Q1 2021

May 14, 2021
BUY
$33.49 - $37.77 $404,525 - $456,223
12,079 Added 7.25%
178,760 $6.48 Million
Q4 2020

Feb 12, 2021
BUY
$33.47 - $42.56 $791,833 - $1.01 Million
23,658 Added 16.54%
166,681 $6.14 Million
Q3 2020

Nov 13, 2020
BUY
$31.75 - $37.25 $439,356 - $515,465
13,838 Added 10.71%
143,023 $5.25 Million
Q2 2020

Aug 14, 2020
SELL
$30.12 - $36.54 $384,270 - $466,177
-12,758 Reduced 8.99%
129,185 $4.22 Million
Q1 2020

May 14, 2020
SELL
$27.03 - $38.62 $362,066 - $517,314
-13,395 Reduced 8.62%
141,943 $4.63 Million
Q4 2019

Feb 14, 2020
SELL
$32.92 - $37.36 $7.63 Million - $8.66 Million
-231,672 Reduced 59.86%
155,338 $6.09 Million
Q3 2019

Nov 14, 2019
BUY
$32.49 - $42.13 $302,092 - $391,724
9,298 Added 2.46%
387,010 $13.9 Million
Q2 2019

Aug 12, 2019
BUY
$36.98 - $41.52 $236,930 - $266,018
6,407 Added 1.73%
377,712 $16.4 Million
Q1 2019

May 15, 2019
BUY
$37.5 - $41.2 $448,162 - $492,381
11,951 Added 3.33%
371,305 $15.8 Million
Q4 2018

Feb 15, 2019
BUY
$38.47 - $43.86 $155,187 - $176,931
4,034 Added 1.14%
359,354 $15.7 Million
Q3 2018

Nov 13, 2018
BUY
$34.47 - $41.81 $2.22 Million - $2.7 Million
64,468 Added 22.17%
355,320 $15.7 Million
Q2 2018

Aug 10, 2018
BUY
$32.98 - $35.16 $45,908 - $48,942
1,392 Added 0.48%
290,852 $10.6 Million
Q1 2018

May 15, 2018
BUY
$31.91 - $37.02 $259,779 - $301,379
8,141 Added 2.89%
289,460 $10.3 Million
Q4 2017

Feb 14, 2018
BUY
$33.26 - $35.29 $533,357 - $565,910
16,036 Added 6.04%
281,319 $10.2 Million
Q3 2017

Nov 14, 2017
BUY
$31.0 - $34.15 $8.22 Million - $9.06 Million
265,283
265,283 $9.47 Million

Others Institutions Holding PFE

# of Institutions
3,260
Shares Held
3.73B
Call Options Held
73.5M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email